HCA Healthcare (HCA) to Release Quarterly Earnings on Friday

HCA Healthcare (NYSE:HCA) is set to issue its quarterly earnings data before the market opens on Friday, April 26th. Analysts expect the company to announce earnings of $4.92 per share for the quarter. HCA Healthcare has set its FY24 guidance at $19.70-21.20 EPS and its FY 2024 guidance at 19.700-21.200 EPS.Parties interested in registering for the company’s conference call can do so using this link.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, January 30th. The company reported $5.90 EPS for the quarter, topping the consensus estimate of $5.05 by $0.85. HCA Healthcare had a net margin of 8.07% and a return on equity of 996.30%. The company had revenue of $17.30 billion during the quarter, compared to analysts’ expectations of $16.51 billion. During the same period last year, the company posted $4.64 earnings per share. The business’s revenue for the quarter was up 11.7% on a year-over-year basis. On average, analysts expect HCA Healthcare to post $21 EPS for the current fiscal year and $23 EPS for the next fiscal year.

HCA Healthcare Trading Up 2.9 %

HCA Healthcare stock opened at $319.43 on Wednesday. The firm has a market capitalization of $84.48 billion, a price-to-earnings ratio of 16.83, a P/E/G ratio of 1.47 and a beta of 1.65. HCA Healthcare has a 52 week low of $215.96 and a 52 week high of $335.83. The company has a debt-to-equity ratio of 35.07, a quick ratio of 1.02 and a current ratio of 1.18. The company has a 50 day moving average price of $324.47 and a 200 day moving average price of $293.19.

HCA Healthcare declared that its Board of Directors has approved a share buyback plan on Tuesday, January 30th that authorizes the company to buyback $6.00 billion in outstanding shares. This buyback authorization authorizes the company to repurchase up to 7.4% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s board believes its stock is undervalued.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 29th. Investors of record on Friday, March 15th were issued a dividend of $0.66 per share. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.60. This represents a $2.64 annualized dividend and a dividend yield of 0.83%. The ex-dividend date was Thursday, March 14th. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.91%.

Insider Buying and Selling

In other HCA Healthcare news, SVP Kathryn A. Torres sold 3,861 shares of the stock in a transaction dated Wednesday, January 31st. The shares were sold at an average price of $307.00, for a total transaction of $1,185,327.00. Following the sale, the senior vice president now owns 15,899 shares of the company’s stock, valued at approximately $4,880,993. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, SVP Kathryn A. Torres sold 3,861 shares of the firm’s stock in a transaction dated Wednesday, January 31st. The shares were sold at an average price of $307.00, for a total value of $1,185,327.00. Following the transaction, the senior vice president now owns 15,899 shares of the company’s stock, valued at approximately $4,880,993. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Sammie S. Mosier sold 1,645 shares of the firm’s stock in a transaction dated Monday, February 5th. The shares were sold at an average price of $312.00, for a total transaction of $513,240.00. Following the completion of the transaction, the senior vice president now directly owns 7,646 shares in the company, valued at approximately $2,385,552. The disclosure for this sale can be found here. Insiders sold 14,840 shares of company stock worth $4,588,869 in the last quarter. 1.70% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of research analysts recently commented on HCA shares. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of HCA Healthcare from $330.00 to $359.00 and gave the company a “buy” rating in a research report on Friday, April 12th. StockNews.com raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Monday. Cantor Fitzgerald reissued an “overweight” rating and issued a $335.00 target price on shares of HCA Healthcare in a research report on Wednesday, April 10th. Truist Financial upped their price objective on shares of HCA Healthcare from $320.00 to $345.00 and gave the stock a “buy” rating in a report on Wednesday, January 31st. Finally, Oppenheimer reaffirmed an “outperform” rating and set a $315.00 price objective on shares of HCA Healthcare in a report on Wednesday, January 17th. Four analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $314.05.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.